AGIO

$0.00

(

+0.00%

) Quote details
Add to Watchlist Run Backtest
stock

Agios Pharm

NASDAQ | AGIO

24.57

USD

+$0.00

(

+0.00%

)

At Close (As of Nov 20, 2025)

$1.43B

Market Cap

-

P/E Ratio

-7.01

EPS

$62.45

52 Week High

$22.24

52 Week Low

HEALTHCARE

Sector

AGIO Chart

Recent Chart
Price Action

AGIO Technicals

Tags:

AGIO Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $32M
Total Revenue $36M
Cost Of Revenue $4.2M
Costof Goods And Services Sold $4.2M
Operating Income -$426M
Selling General And Administrative $157M
Research And Development $301M
Operating Expenses $458M
Investment Income Net -
Net Interest Income $48M
Interest Income $48M
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $5.7M
Income Before Tax $718M
Income Tax Expense $44M
Interest And Debt Expense -
Net Income From Continuing Operations $674M
Comprehensive Income Net Of Tax -
Ebit -$426M
Ebitda -$420M
Net Income $674M

Revenue & Profitability

Earnings Performance

AGIO Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $1.7B
Total Current Assets $966M
Cash And Cash Equivalents At Carrying Value $76M
Cash And Short Term Investments $76M
Inventory $28M
Current Net Receivables $4.1M
Total Non Current Assets $698M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets -
Intangible Assets Excluding Goodwill -
Goodwill -
Investments -
Long Term Investments $638M
Short Term Investments $817M
Other Current Assets $40M
Other Non Current Assets -
Total Liabilities $122M
Total Current Liabilities $81M
Current Accounts Payable $17M
Deferred Revenue -
Current Debt -
Short Term Debt $17M
Total Non Current Liabilities $41M
Capital Lease Obligations $57M
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $57M
Other Current Liabilities $47M
Other Non Current Liabilities $880K
Total Shareholder Equity $1.5B
Treasury Stock -
Retained Earnings -$149M
Common Stock $73K
Common Stock Shares Outstanding $58M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$390M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $5.7M
Capital Expenditures $1.7M
Change In Receivables -
Change In Inventory -$8.5M
Profit Loss -
Cashflow From Investment $363M
Cashflow From Financing $14M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income $674M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $32M
Total Revenue $36M
Cost Of Revenue $4.2M
Costof Goods And Services Sold $4.2M
Operating Income -$426M
Selling General And Administrative $157M
Research And Development $301M
Operating Expenses $458M
Investment Income Net -
Net Interest Income $48M
Interest Income $48M
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $5.7M
Income Before Tax $718M
Income Tax Expense $44M
Interest And Debt Expense -
Net Income From Continuing Operations $674M
Comprehensive Income Net Of Tax -
Ebit -$426M
Ebitda -$420M
Net Income $674M

AGIO News

AGIO Profile

Agios Pharm Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Agios Pharmaceuticals, Inc. is a prominent biopharmaceutical company headquartered in Cambridge, Massachusetts, dedicated to developing transformative therapies targeting diseases related to cellular metabolism. With a strong focus on oncology and rare genetic disorders, Agios utilizes its extensive knowledge of metabolic pathways to create innovative treatments that exemplify precision medicine. The company boasts a promising pipeline and actively engages in strategic collaborations to enhance research and development efforts, demonstrating its commitment to advancing scientific understanding and significantly improving patient outcomes through state-of-the-art therapeutic solutions.

LPTX
+368.57%
$2.05
SOND
+79.15%
$0.16
BNKK
+19.70%
$0.17
NVDA
-3.15%
$180.64
IVP
+18.43%
$0.12
VHAI
-50.00%
$0.00
ONDS
-16.40%
$6.27
TSLA
-2.16%
$395.23
WTO
-14.65%
$0.01
PLUG
-0.52%
$1.89
BYND
-9.80%
$0.88
ASST
-6.40%
$0.98
SOFI
-6.77%
$24.91
INTC
-4.24%
$33.62
F
-3.79%
$12.41
SGBX
-37.06%
$3.82
CIFR
-0.41%
$14.56
GRAB
-6.21%
$4.98
VIVK
-9.58%
$0.11
BITF
0.00%
$2.60
PLTR
-5.84%
$155.74
AIIO
+41.76%
$0.78
NWTN
+41.76%
$0.78
DNN
-4.52%
$2.32
WULF
-5.47%
$11.56
NVVE
-15.67%
$0.16
ACHR
-8.03%
$6.87
NIO
-6.08%
$5.40
MNDR
+83.13%
$3.04
EXAS
+16.81%
$100.67
AXDX
-61.36%
$0.03
AMD
-7.84%
$206.02
AUID
+5.55%
$1.71
IREN
-5.14%
$43.47
GOOGL
-1.14%
$289.45
BMNR
-10.82%
$26.02
AAL
-0.72%
$12.24
NOK
-2.65%
$5.87
MARA
-7.74%
$10.24
RGTI
-10.44%
$22.80
DVLT
+8.75%
$1.74
SOUN
-2.92%
$11.29
PFE
-1.92%
$24.40
ADAP
-15.14%
$0.05
WMT
+6.46%
$107.11
AMZN
-2.49%
$217.14
SNAP
-3.11%
$7.78
MU
-10.86%
$201.37
WBD
-0.90%
$22.88
CHR
-7.57%
$0.05
AAPL
-0.86%
$266.25
RIVN
-0.40%
$14.66
RIG
-6.34%
$3.84
EOSE
+0.78%
$12.88
ABEV
-1.61%
$2.43
NFE
+25.86%
$1.46
T
+0.98%
$25.52
PLTD
+5.82%
$7.63
AZI
-18.11%
$0.06
BURU
-10.54%
$0.18
HOOD
-10.11%
$106.21
TLRY
-6.53%
$0.89
UBER
-6.89%
$83.36
BBWI
-24.80%
$15.82
CRWV
-7.62%
$69.21
QBTS
-12.50%
$20.51
RMBL
+60.50%
$3.21
LNW
-3.71%
$86.22
RXRX
-4.46%
$3.85
PCG
+0.76%
$15.84
APLD
-7.44%
$21.37
ADD
-25.47%
$0.05
SMCI
-6.43%
$31.56
CAN
-4.08%
$0.92
NFLX
-3.93%
$105.67
CYPH
0.00%
$2.94
BBD
-1.69%
$3.48
BAC
-1.96%
$51.00
NBIS
-10.97%
$84.64
BTBT
-5.09%
$2.05
IONZ
+28.40%
$6.42
BULL
+0.36%
$8.25
SRM
+53.27%
$10.30
QUBT
-11.15%
$10.27
GOOG
-1.02%
$289.98
IONQ
-14.36%
$41.00
BTG
-4.53%
$3.79
NVTS
-2.20%
$7.55
LEN
+0.94%
$116.25
LAES
-7.86%
$3.63
VZ
-1.04%
$40.76
PLTZ
+11.57%
$8.48
SMR
-11.50%
$18.70
RZLV
-0.66%
$2.99
VALE
-1.65%
$11.92
BTE
-0.62%
$3.16
CLSK
-4.30%
$9.78
BMNU
-22.39%
$5.37
CGC
-3.80%
$1.01
HBAN
-0.39%
$15.32
LPTX
+368.57%
$2.05
SOND
+79.15%
$0.16
BNKK
+19.70%
$0.17
NVDA
-3.15%
$180.64
IVP
+18.43%
$0.12
VHAI
-50.00%
$0.00
ONDS
-16.40%
$6.27
TSLA
-2.16%
$395.23
WTO
-14.65%
$0.01
PLUG
-0.52%
$1.89
BYND
-9.80%
$0.88
ASST
-6.40%
$0.98
SOFI
-6.77%
$24.91
INTC
-4.24%
$33.62
F
-3.79%
$12.41
SGBX
-37.06%
$3.82
CIFR
-0.41%
$14.56
GRAB
-6.21%
$4.98
VIVK
-9.58%
$0.11
BITF
0.00%
$2.60
PLTR
-5.84%
$155.74
AIIO
+41.76%
$0.78
NWTN
+41.76%
$0.78
DNN
-4.52%
$2.32
WULF
-5.47%
$11.56
NVVE
-15.67%
$0.16
ACHR
-8.03%
$6.87
NIO
-6.08%
$5.40
MNDR
+83.13%
$3.04
EXAS
+16.81%
$100.67
AXDX
-61.36%
$0.03
AMD
-7.84%
$206.02
AUID
+5.55%
$1.71
IREN
-5.14%
$43.47
GOOGL
-1.14%
$289.45
BMNR
-10.82%
$26.02
AAL
-0.72%
$12.24
NOK
-2.65%
$5.87
MARA
-7.74%
$10.24
RGTI
-10.44%
$22.80
DVLT
+8.75%
$1.74
SOUN
-2.92%
$11.29
PFE
-1.92%
$24.40
ADAP
-15.14%
$0.05
WMT
+6.46%
$107.11
AMZN
-2.49%
$217.14
SNAP
-3.11%
$7.78
MU
-10.86%
$201.37
WBD
-0.90%
$22.88
CHR
-7.57%
$0.05
AAPL
-0.86%
$266.25
RIVN
-0.40%
$14.66
RIG
-6.34%
$3.84
EOSE
+0.78%
$12.88
ABEV
-1.61%
$2.43
NFE
+25.86%
$1.46
T
+0.98%
$25.52
PLTD
+5.82%
$7.63
AZI
-18.11%
$0.06
BURU
-10.54%
$0.18
HOOD
-10.11%
$106.21
TLRY
-6.53%
$0.89
UBER
-6.89%
$83.36
BBWI
-24.80%
$15.82
CRWV
-7.62%
$69.21
QBTS
-12.50%
$20.51
RMBL
+60.50%
$3.21
LNW
-3.71%
$86.22
RXRX
-4.46%
$3.85
PCG
+0.76%
$15.84
APLD
-7.44%
$21.37
ADD
-25.47%
$0.05
SMCI
-6.43%
$31.56
CAN
-4.08%
$0.92
NFLX
-3.93%
$105.67
CYPH
0.00%
$2.94
BBD
-1.69%
$3.48
BAC
-1.96%
$51.00
NBIS
-10.97%
$84.64
BTBT
-5.09%
$2.05
IONZ
+28.40%
$6.42
BULL
+0.36%
$8.25
SRM
+53.27%
$10.30
QUBT
-11.15%
$10.27
GOOG
-1.02%
$289.98
IONQ
-14.36%
$41.00
BTG
-4.53%
$3.79
NVTS
-2.20%
$7.55
LEN
+0.94%
$116.25
LAES
-7.86%
$3.63
VZ
-1.04%
$40.76
PLTZ
+11.57%
$8.48
SMR
-11.50%
$18.70
RZLV
-0.66%
$2.99
VALE
-1.65%
$11.92
BTE
-0.62%
$3.16
CLSK
-4.30%
$9.78
BMNU
-22.39%
$5.37
CGC
-3.80%
$1.01
HBAN
-0.39%
$15.32
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.